Mot de passe
Mot de passe oublié ?
Devenir membre gratuitement
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Cotations dynamiques 

Accueil Zonebourse  >  Actions  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267


Fonds positionnés sur NOVARTIS
NomPEA1er Jan5 ansNotationPosition
Aviva Investors European Eq I EUR AccNON20.00%38.00%5.64M EUR
Aviva Investors Eurp Eq Inc A EUR AccNON9.00%14.00%73.16M EUR
Capital Group Eurp Gr&Inc (LUX) Z AccNON17.00%29.00%3.92M EUR
CPR Invest Europe Spec Situations I AccNON16.00%0.00%NC0.85M EUR
CS (Lux) European Div Plus Eq DB EURNON17.00%32.00%8.75M EUR
DPAM Capital B Equities Europe Idx F CapNON17.00%27.00%14.01M EUR
DWS Invest II Eurp Top Div LDNON14.00%19.00%9.81M EUR
FP CRUX European Special Sit I Acc GBPNON18.00%50.00%5.78M GBP
Invesco Continental Eur Eq A EUR ADNON9.00%16.00%0.85M EUR
Invesco Pan European Eq Inc A EUR AccNON10.00%16.00%2M EUR
Invesco Pan European Hi Inc A EUR AccNON9.00%17.00%82.89M EUR
Invesco UK Equity Income Z USD AccNON0.00%0.00%NC5.78M USD
Investec GSF Glb Qual Eq Inc S Inc USDNON22.00%81.00%73.16M USD
IShares Europe ex-UK Idx (IE) Flex Acc€NON19.00%38.00%78.85M EUR
M&G (Lux) Eurp Strat Val CI EUR AccNON10.00%22.00%31.33M EUR
M&G European Index Tracker Euro A AccNON19.00%35.00%2.7M EUR
Merian European Equity A EUR AccNON17.00%5.00%0.95M EUR
Metropole Selection ANON11.00%10.00%31.33M EUR
Nordea 1 - European Focus Equity BP EURNON23.00%0.00%10.01M EUR
Nordea 1 - European Stars Equity BI EURNON23.00%0.00%NC0.79M EUR
Pictet-Europe Index I EURNON17.00%29.00%32.67M EUR
Schroder ISF Global Eq Alp C Acc USDNON21.00%60.00%32.63M USD
Schroder ISF Swiss Eq Opports A Acc CHFNON18.00%33.00%2.07M CHF
Schroder ISF Swiss Equity A Acc CHFNON21.00%45.00%0.05M CHF
Swiss Life (LUX) Pf Glb Gr (CHF) RNON16.00%31.00%0.62M CHF
Threadneedle (Lux) Glbl Mlt Ast Inc AECNON9.00%0.00%3.17M EUR
Threadneedle (Lux) Global Eq Inc 2EP EURNON19.00%44.00%16.24M EUR
Threadneedle Glbl Eq Inc Ins X Acc GBPNON21.00%50.00%NC6.15M GBP
UBAM Swiss Equity IC CHFNON26.00%62.00%129.77M CHF
UBS (Lux) EF Health Care (USD) PNON16.00%61.00%9.59M USD
UBS (Lux) ES Swiss Opp (CHF) P-accNON21.00%51.00%5.22M CHF
UBS (Lux) IF Key Sel Euro Equity AD-T2NON10.00%26.00%1.84M EUR
UBS (Lux) SF Equity (CHF) P-accNON17.00%32.00%10.89M CHF

Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique NOVARTIS
Durée : Période :
Novartis : Graphique analyse technique Novartis | NOVN | CH0012005267 | Zone bourse
Evolution du Compte de Résultat
Recommandation moyenne ACCUMULER
Nombre d'Analystes 27
Objectif de cours Moyen 93,32  $
Dernier Cours de Cloture 93,80  $
Ecart / Objectif Haut 14,5%
Ecart / Objectif Moyen -0,52%
Ecart / Objectif Bas -18,5%
Révisions de BNA
Secteur et Concurrence
Var. 1janvCapitalisation (M$)
NOVARTIS24.44%215 148
JOHNSON & JOHNSON-0.32%341 546
PFIZER-1.90%237 728
ROCHE HOLDING LTD.8.73%230 511
ROCHE HOLDING10.69%230 511